SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-023664
Filing Date
2019-06-27
Accepted
2019-06-27 08:00:38
Documents
4
Period of Report
2019-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atrs-8k_20190626.htm 8-K 45034
2 EX-10.1 FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT atrs-ex101_22.htm EX-10.1 72868
3 EX-99.1 PRESS RELEASE atrs-ex991_6.htm EX-99.1 19547
4 GRAPHIC g4usoei4yctb000001.jpg GRAPHIC 17898
  Complete submission text file 0001564590-19-023664.txt   163892
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 19922977
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10